TotalMarketCap

Shuttle Pharmaceuticals

SHPHNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$24.348 M

$5.11 -1.92%

Close of 6 Nov 2026

As of 6 Nov 2026, Shuttle Pharmaceuticals (SHPH) has a market capitalization of $24.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$11.7M

Loss-making

Shares outstanding

4,764,696

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #371Transcode TherapeuticsRNAZ$25.4M
  2. #372Aardvark TherapeuticsAARD$24.5M
  3. #373Shuttle PharmaceuticalsSHPH$24.3M
  4. #374CelularityCELU$23.7M
  5. #375NextCureNXTC$23.6M

What if Shuttle Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,926,270

Per share 1,159,740× higher

Bitcoin $1.53T

$320,660.13

Per share 62,751× higher

Apple $5.02T

$1,052,697

Per share 206,007× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Shuttle Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.